Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies

1. Cook, DJ, Griffith, LE, Walter, SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5(6):368-375. doi:10.1186/cc1071.
Google Scholar | Crossref | Medline | ISI2. Maynard, N, Bihari, D, Beale, R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA. 1993;270:1203-1210. doi:10.1001/jama.1993.03510100053032.
Google Scholar | Crossref | Medline | ISI3. Skillman, JJ, Bushnell, LS, Goldman, H, Silen, W. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach. Am J Surg. 1969;117(4):523-530. doi:10.1016/0002-9610(69)90011-7.
Google Scholar | Crossref | Medline4. Krag, M, Perner, A, Møller, MH. Stress ulcer prophylaxis in the intensive care unit. Curr Opin Crit Care. 2016;22:186-190. doi:10.1097/MCC.0000000000000290.
Google Scholar | Crossref | Medline5. Wang, Y, Ge, L, Ye, Z, et al. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials. Intensive Care Med. 2020;46(11):1987-2000. doi:10.1007/s00134-020-06209-w.
Google Scholar | Crossref | Medline6. Madsen, KR, Lorentzen, K, Clausen, N, et al. Guideline for stress ulcer prophylaxis in the intensive care unit. Dan Med J. 2014;61(3):C4811.
Google Scholar | Medline7. Dellinger, RP, Levy, MM, Rhodes, A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637. doi:10.1097/CCM.0b013e31827e83af.
Google Scholar | Crossref | Medline | ISI8. Rhodes, A, Evans, LE, Alhazzani, W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304-377. doi:10.1007/s00134-017-4683-6.
Google Scholar | Crossref | Medline | ISI9. Ye, Z, Reintam Blaser, A, Lytvyn, L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020;368:l6722. doi:10.1136/bmj.l6722.
Google Scholar | Crossref | Medline10. Krag, M, Perner, A, Wetterslev, J, et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiol Scand. 2015;59(5):576-585. doi:10.1111/aas.12508.
Google Scholar | Crossref | Medline11. Arabi, YM, Perner, A. Focus on fluid therapy and nutritional support. Intensive Care Med. 2018;44(12):2271-2273. doi:10.1007/s00134-018-5429-9.
Google Scholar | Crossref | Medline12. Krag, M, Perner, A, Wetterslev, J, et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med. 2015;41(5):833-845. doi:10.1007/s00134-015-3725-1.
Google Scholar | Crossref | Medline13. Litton, E, Eastwood, GM, Bellomo, R, et al. A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data. Crit Care Resusc. 2014;16(3):158-163.
Google Scholar | Medline14. Al-Dorzi, HM, Arabi, YM. Prevention of gastrointestinal bleeding in critically ill patients. Curr Opin Crit Care. 2021;27:177-182. doi:10.1097/mcc.0000000000000803.
Google Scholar | Crossref | Medline15. Young, PJ, Bagshaw, SM, Forbes, AB, et al. Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial. JAMA. 2020;323:616-626. doi:10.1001/jama.2019.22190.
Google Scholar | Crossref | Medline16. Toews, I, George, AT, Peter, JV, et al. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Database Syst Rev. 2018;6:CD008687. doi:10.1002/14651858.CD008687.pub2.
Google Scholar | Crossref | Medline17. Deliwala, SS, Hamid, K, Goyal, H, et al. Proton pump inhibitors versus histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: a meta-analysis and trial sequential analysis [published online ahead of print May 28, 2021]. J Clin Gastroenterol. doi:10.1097/MCG.0000000000001562.
Google Scholar | Crossref18. MacLaren, R, Reynolds, PM, Allen, RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014;174:564-574. doi:10.1001/jamainternmed.2013.14673.
Google Scholar | Crossref | Medline | ISI19. Lilly, CM, Aljawadi, M, Badawi, O, et al. Comparative effectiveness of proton pump inhibitors vs histamine type 2 receptor blockers for preventing clinically important gastrointestinal bleeding during intensive care: a population-based study. Chest. 2018;154(3):557-566. doi:10.1016/j.chest.2018.05.015.
Google Scholar | Crossref | Medline20. Page, MJ, McKenzie, JE, Bossuyt, PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
Google Scholar | Crossref | Medline21. Stroup, DF, Berlin, JA, Morton, SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012. doi:10.1001/jama.283.15.2008.
Google Scholar | Crossref | Medline | ISI22. Wells, G, Shea, B, O’Connell, D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
Google Scholar23. Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926. doi:10.1136/bmj.39489.470347.AD.
Google Scholar | Crossref | Medline24. Cook, D, Guyatt, G. Prophylaxis against upper gastrointestinal bleeding in hospitalized patients. N Engl J Med. 2018;378:2506-2516. doi:10.1056/NEJMra1605507.
Google Scholar | Crossref | Medline25. Cummings, P . The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438-445. doi:10.1001/archpediatrics.2009.31.
Google Scholar | Crossref | Medline26. Cook, D, Guyatt, G, Marshall, J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med. 1998;338:791-797. doi:10.1056/NEJM199803193381203.
Google Scholar | Crossref | Medline | ISI27. Lee, TC, Goodwin Wilson, M, Lawandi, A, McDonald, EG. Proton pump inhibitors versus histamine-2 receptor antagonists likely increase mortality in critical care: an updated meta-analysis. Am J Med. 2021;134(3):e184-e188. doi:10.1016/j.amjmed.2020.08.004.
Google Scholar | Crossref | Medline28. Barletta, JF . Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock. Ann Pharmacother. 2014;48(10):1276-1281. doi:10.1177/1060028014540513.
Google Scholar | SAGE Journals | ISI29. Bruno, JJ, Canada, TW, Wakefield, CD, Nates, JL. Stress-related mucosal bleeding in critically ill oncology patients. J Oncol Pharm Pract. 2009;15:9-16. doi:10.1177/1078155208094122.
Google Scholar | SAGE Journals30. Buendgens, L, Bruensing, J, Matthes, M, et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. J Crit Care. 2014;29(4):696.e11-5. doi:10.1016/j.jcrc.2014.03.002.
Google Scholar | Crossref | Medline31. Hsieh, HC, Lin, TH, Lee, MC, et al. Proton pump inhibitors vs histamine-2 receptor antagonists and risk of mortality in critically ill patients: a pilot analysis of multi-institutional study. Pharmacoepidemiol Drug Saf. 2019;28:577-578.
Google Scholar32. Kondo, Y, Ohbe, H, Matsui, H, Fushimi, K, Tanaka, H, Yasunaga, H. Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis. BMJ Open. 2020;10:e037534. doi:10.1136/bmjopen-2020-037534.
Google Scholar | Crossref | Medline33. Ojiako, K, Shingala, H, Schorr, C, Gerber, DR. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation. Am J Crit Care. 2008;17(2):142-147. doi:10.4037/ajcc2008.17.2.142.
Google Scholar | Crossref | Medline34. Sadaka, F, Trottier, S, Smith, T, et al. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis. Crit Care Med. 2013;41:A224. doi:10.1097/01.ccm.0000440132.04901.39.
Google Scholar | Crossref | Medline35. Suzuki, J, Sasabuchi, Y, Hatakeyama, S, et al. Histamine-2 receptor antagonists versus proton pump inhibitors for septic shock after lower gastrointestinal tract perforation: a retrospective cohort study using a national inpatient database. J Intensive Care. 2020;8:56. doi:10.1186/s40560-020-00473-0.
Google Scholar | Crossref | Medline36. Song, MJ, Kim, S, Boo, D, et al. Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit. Sci Rep. 2021;11:18467. doi:10.1038/s41598-021-98069-7.
Google Scholar | Crossref | Medline37. Boyd, C, Hassig, T, MacLaren, R. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU. Pharmacotherapy. 2021;41:820-827. doi:10.1002/phar.2621.
Google Scholar | Crossref | Medline38. Huang, M, Han, M, Han, W, Kuang, L. Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study. J Int Med Res. 2021;49(6):3000605211025130. doi:10.1177/03000605211025130.
Google Scholar | SAGE Journals39. Wang, Y, Ye, Z, Ge, L, et al. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis. BMJ. 2020;368:l6744. doi:10.1136/bmj.l6744.
Google Scholar | Crossref | Medline40. Alhazzani, W, Alshamsi, F, Belley-Cote, E, et al. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018;44:1-11. doi:10.1007/s00134-017-5005-8.
Google Scholar | Crossref | Medline41. Brophy, GM, Brackbill, ML, Bidwell, KL, Brophy, DF. Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. Neurocrit Care. 2010;13(2):176-181. doi:10.1007/s12028-010-9397-3
Google Scholar | Crossref | Medline42. Conrad, SA, Gabrielli, A, Margolis, B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33(4):760-765. doi:10.1097/01.ccm.0000157751.92249.32.
Google Scholar | Crossref | Medline43. Levy, MJ, Seelig, CB, Robinson, NJ, Ranney, JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci. 1997;42(6):1255-1259. doi:10.1023/a:1018810325370.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif